Showing results (161-170 of 207) with videos related to
Sort By:
Pageof 21
Pain Medicine (Malden, Mass.)|October 10, 2013
A phase 2a, randomized, crossover trial of gabapentin enacarbil for the treatment of postherpetic neuralgia in gabapentin inadequate respondersR Norman Harden, Roy Freeman, Michelle Rainka, et al.Journal of Neuropathology and Experimental Neurology|January 11, 2017
The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson DiseaseJohn M Lee, Pascal Derkinderen, Jeffrey H Kordower, et al.Oncology Nursing Forum|August 24, 2025
Association Between the CEP72 Genotype and Chemotherapy-Induced Peripheral Neuropathy Severity in Young Adults Receiving Vincristine or PaclitaxelRobert Knoerl, Emanuele Mazzola, Maria F Pazyra-Murphy, et al.Neurology. Genetics|December 22, 2017
NaV channel variants in patients with painful and nonpainful peripheral neuropathySamir Wadhawan, Saumya Pant, Ryan Golhar, et al.The Clinical Journal of Pain|March 27, 2023
Cannabinoid Therapy: Attitudes and Experiences of People With Chronic PainJennifer S Gewandter, Robert R Edwards, Kevin P Hill, et al.The Journal of Pain|April 23, 2013
A randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748)Lixin Zhang, Michelle Rainka, Roy Freeman, et al.Diabetes Care|July 22, 2011
Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trialDan Ziegler, Phillip A Low, William J Litchy, et al.Journal of the Peripheral Nervous System : JPNS|May 6, 2024
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidisKarla Cárdenas-Soto, Xel-Ha Dominguez, Giovanni Cortes, et al.Pain|March 6, 2021
Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathyAndrew S C Rice, Robert H Dworkin, Nanna B Finnerup, et al.Pain Medicine (Malden, Mass.)|October 4, 2024
Personalized outcomes in neuropathic pain: a clinical relevance and assay sensitivity analysis from a randomized controlled trialKarim Saab, Umang Gada, Eva Culakova, et al.Pageof 21